Dr. David Oladejo is a creative and result-driven clinical research scientist with the ability to use molecular biology techniques to understand and manipulate the genetic, chemical, and physical components of living organisms and to design drugs and therapies that enhance the quality of human life. His research has focused on biomarkers associated with antimalarial drug resistance, anti-malarial drug design, discovery, and transcriptional regulation of gene expression in Plasmodium falciparum. He has experience in molecular biology techniques such as DNA, RNA, and protein extraction, polymerase chain reaction (PCR), and sequencing to research cell organization and function, including mechanisms of gene expression, cellular bioinformatics, cell signaling, or cell differentiation, and works to strict regulatory and quality standards to ensure experiments are safe.